Table 6.

Duration of hospitalization and antimicrobial treatment associated with microbiological diagnoses among patients who died (n=37)

			Died
	Total Na	Survived	Total died	P . f.	P . v.	P. f + lepto-spirosis	Lepto-spirosis	Bacteremiab	Scrub typhus	Scrub and lepto-spirosis	Scrub and dengue	Dengue	No microbiol. diagnosis
Total, N	1521	1484	37	2	3	2	1	2	3c	1	2	2	19
Duration in hospital, median (IQR), dd	1270	4 (3–5)	3 (1–4)
Antimalarials, n (%)
Artemisinine and/or quinine				2	3	2
Artesunate	233	215 (92)	18 (8)		3	1			1		1	1	11
Artemether	31	26 (84)	5 (16)	2		1							2
Quinine	21	15 (71)	6 (29)	2		1							3
Chloroquine	93	87 (94)	6 (7)	2		1							3
Primaquine	50	49 (98)	1 (2)	1
Mefloquine	6	4 (67)	2 (33)										2
Sulphadox/pyrimeth	4	3 (75)	1 (25)	1					1			1	1
Antibiotics, n (%)
3. gen cephalosporin	971	944 (97)	27 (3)			2	1	1	2	1	1	1	17
2. gen cephalosporin	38	37 (97)	1 (3)									1
1. gen cephalosporin	27	26 (96)	1 (4)		1
Carbapenem	6	6 (100)	0
Penicillin	117	105 (90)	12 (10)	2	1	1	1						7
Aminoglycoside	71	63 (89)	8 (11)	2		1			1				4
Piperacillin/tazobactam	54	49 (91)	5 (9)						1			2	2
Quinolone	62	60 (97)	2 (3)									1	1
Macrolide	123	122 (99)	1 (1)					1
Tetracycline	609	586 (92)	23 (4)		2	1	1	1	3	1	2		12
Clindamycin	3	2	1						1

^aTotal number investigated among 1521 patients. Discrepancies due to missing values.

^b S. aureus case had received three antibiotics and E. coli case no antibiotics.

^cOne patient was Scrub ELISA positive and IFA negative, but diagnosis confirmed by eschar.

^d9/32 (28%) died day 1, 6/32 day 2 and 7/32 day 3. Mann Whitney U test p=0.001.